TerrAscend Corp. (TSNDF)
OTCMKTS · Delayed Price · Currency is USD
0.7300
-0.0348 (-4.55%)
Dec 31, 2025, 9:32 AM EST
TerrAscend Market Cap
TerrAscend has a market cap or net worth of $220.11 million as of December 31, 2025. Its market cap has increased by 10.92% in one year.
Market Cap
220.11M
Enterprise Value
442.74M
Revenue
299.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.73
Market Cap Chart
Since May 3, 2017, TerrAscend's market cap has increased from 25.82M to 220.11M, an increase of 752.57%. That is a compound annual growth rate of 28.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 220.11M | 18.27% |
| Dec 31, 2024 | 186.10M | -61.11% |
| Dec 29, 2023 | 478.56M | 61.26% |
| Dec 30, 2022 | 296.76M | -74.68% |
| Dec 31, 2021 | 1.17B | -24.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 748.72M |
| Elite Pharmaceuticals | 537.07M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 379.67M |
| CytoDyn | 353.44M |
| Silence Therapeutics | 292.85M |
| Nika Pharmaceuticals | 291.10M |